Cellosaurus logo
expasy logo

Cellosaurus 585A1 (CVCL_DQ06)

[Text version]
Cell line name 585A1
Synonyms HPS0354
Accession CVCL_DQ06
Resource Identification Initiative To cite this cell line use: 585A1 (RRID:CVCL_DQ06)
Comments From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
Population: Japanese.
Omics: Deep proteome analysis.
Omics: DNA methylation analysis.
Omics: Transcriptome analysis by microarray.
Omics: Transcriptome analysis by RNAseq.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
HLA typing Source: PubMed=30853558
Class I
HLA-AA*24:02
HLA-BB*07:02,52:01
HLA-CC*07:02,12:02
Class II
HLA-DRDRB1*01:01,15:01
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_VS01 (23C27)CVCL_C1FM (585A1-B2M-KO)CVCL_C1FZ (585A1-C7 #3-1)
CVCL_C1G0 (585A1-C7 #3-3)
Originate from same individual CVCL_DQ07 ! 585B1
CVCL_DQ20 ! 692D2
CVCL_LJ36 ! 692E1
CVCL_DQ21 ! 703A1
CVCL_DQ22 ! 703B1
Sex of cell Male
Age at sampling 30-39Y
Category Induced pluripotent stem cell
Publications

PubMed=22802639; DOI=10.1073/pnas.1209979109
Kajiwara M., Aoi T., Okita K., Takahashi R., Inoue H., Takayama N., Endo H., Eto K., Toguchida J., Uemoto S., Yamanaka S.
Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells.
Proc. Natl. Acad. Sci. U.S.A. 109:12538-12543(2012)

PubMed=23193063; DOI=10.1002/stem.1293
Okita K., Yamakawa T., Matsumura Y., Sato Y., Amano N., Watanabe A., Goshima N., Yamanaka S.
An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells.
Stem Cells 31:458-466(2013)

PubMed=23210603; DOI=10.1021/pr300837u
Yamana R., Iwasaki M., Wakabayashi M., Nakagawa M., Yamanaka S., Ishihama Y.
Rapid and deep profiling of human induced pluripotent stem cell proteome by one-shot NanoLC-MS/MS analysis with meter-scale monolithic silica columns.
J. Proteome Res. 12:214-221(2013)

PubMed=24259714; DOI=10.1073/pnas.1319061110
Koyanagi-Aoi M., Ohnuki M., Takahashi K., Okita K., Noma H., Sawamura Y., Teramoto I., Narita M., Sato Y., Ichisaka T., Amano N., Watanabe A., Morizane A., Yamada Y., Sato T., Takahashi J., Yamanaka S.
Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells.
Proc. Natl. Acad. Sci. U.S.A. 110:20569-20574(2013)

PubMed=25665923; DOI=10.1016/j.scr.2015.01.007
Toyoda T., Mae S.-i., Tanaka H., Kondo Y., Funato M., Hosokawa Y., Sudo T., Kawaguchi Y., Osafune K.
Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells.
Stem Cell Res. 14:185-197(2015)

PubMed=26189426; DOI=10.1016/j.stem.2015.06.014
Sasaki K., Yokobayashi S., Nakamura T., Okamoto I., Yabuta Y., Kurimoto K., Ohta H., Moritoki Y., Iwatani C., Tsuchiya H., Nakamura S., Sekiguchi K., Sakuma T., Yamamoto T., Mori T., Woltjen K., Nakagawa M., Yamamoto T., Takahashi K., Yamanaka S., Saitou M.
Robust in vitro induction of human germ cell fate from pluripotent stem cells.
Cell Stem Cell 17:178-194(2015)

PubMed=27476965; DOI=10.1016/j.stem.2016.06.019
Nishizawa M., Chonabayashi K., Nomura M., Tanaka A., Nakamura M., Inagaki A., Nishikawa M., Takei I., Oishi A., Tanabe K., Ohnuki M., Yokota H., Koyanagi-Aoi M., Okita K., Watanabe A., Takaori-Kondo A., Yamanaka S., Yoshida Y.
Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity.
Cell Stem Cell 19:341-354(2016)

PubMed=28453617; DOI=10.1093/biolre/iox038
Yokobayashi S., Okita K., Nakagawa M., Nakamura T., Yabuta Y., Yamamoto T., Saitou M.
Clonal variation of human induced pluripotent stem cells for induction into the germ cell fate.
Biol. Reprod. 96:1154-1166(2017)

PubMed=30735882; DOI=10.1016/j.scr.2019.101400
Matsui S., Ochiai M., Yasuda K., Mae S.-i., Kotaka M., Toyoda T., Yamamoto T., Osafune K.
Differentiation and isolation of iPSC-derived remodeling ductal plate-like cells by use of an AQP1-GFP reporter human iPSC line.
Stem Cell Res. 35:101400-101400(2019)

PubMed=30853558; DOI=10.1016/j.stem.2019.02.005
Xu H.-G., Wang B., Ono M., Kagita A., Fujii K., Sasakawa N., Ueda T., Gee P., Nishikawa M., Nomura M., Kitaoka F., Takahashi T., Okita K., Yoshida Y., Kaneko S., Hotta A.
Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility.
Cell Stem Cell 24:566-578.e7(2019)

Patent=US20200407693
Hotta A., Xu H.-G., Kaneko S., Wang B.
Method for producing low-antigenic cell.
Patent number US20200407693, 31-Dec-2020

Cross-references
Cell line collections (Providers) RCB; HPS0354
Cell line databases/resources SKIP; SKIP000858
Encyclopedic resources Wikidata; Q54603888
Gene expression databases GEO; GSM1040279
GEO; GSM1040349
GEO; GSM1489230
GEO; GSM1489447
GEO; GSM2152683
GEO; GSM2152684
GEO; GSM2152685
GEO; GSM2152686
GEO; GSM2152687
GEO; GSM2152688
GEO; GSM2152689
GEO; GSM2152690
GEO; GSM2592208
GEO; GSM2592209
Proteomic databases PRIDE; PXD000071
Entry history
Entry creation13-Jul-2016
Last entry update29-Jun-2023
Version number10